Skip to main content
. Author manuscript; available in PMC: 2018 Jul 30.
Published in final edited form as: N Engl J Med. 2018 Jun 26;379(2):150–161. doi: 10.1056/NEJMoa1716435

Figure 1. Overall Survival among Patients Who Received PVSRIPO and Historical Controls.

Figure 1

Tick marks indicate censored data. PVSRIPO denotes recombinant nonpathogenic polio–rhinovirus chimera.